Annual FCF
-$110.58 M
-$23.83 M-27.47%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual free cash flow is -$110.58 million, with the most recent change of -$23.83 million (-27.47%) on December 31, 2023.
- During the last 3 years, PRLD annual FCF has fallen by -$63.78 million (-136.28%).
- PRLD annual FCF is now -720.11% below its all-time high of -$13.48 million, reached on December 31, 2018.
Performance
PRLD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.36 M
-$3.94 M-16.84%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly free cash flow is -$27.36 million, with the most recent change of -$3.94 million (-16.84%) on September 30, 2024.
- Over the past year, PRLD quarterly FCF has increased by +$4.72 million (+14.72%).
- PRLD quarterly FCF is now -205.89% below its all-time high of -$8.94 million, reached on June 30, 2020.
Performance
PRLD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$107.56 M
-$1.08 M-1.02%
September 30, 2024
Summary
- As of February 8, 2025, PRLD TTM free cash flow is -$107.56 million, with the most recent change of -$1.08 million (-1.02%) on September 30, 2024.
- Over the past year, PRLD TTM FCF has increased by +$4.15 million (+3.71%).
- PRLD TTM FCF is now -975.51% below its all-time high of -$10.00 million, reached on March 31, 2020.
Performance
PRLD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PRLD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.5% | +14.7% | +3.7% |
| 3 y3 years | -136.3% | -17.3% | -24.0% |
| 5 y5 years | -720.1% | -17.3% | -24.0% |
PRLD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.8% | at low | -42.3% | +14.7% | -25.3% | +3.7% |
| 5 y | 5-year | -318.1% | at low | -205.9% | +14.7% | -975.5% | +3.7% |
| alltime | all time | -720.1% | at low | -205.9% | +14.7% | -975.5% | +3.7% |
Prelude Therapeutics Incorporated Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.36 M(+16.8%) | -$107.56 M(+1.0%) |
| Jun 2024 | - | -$23.42 M(-27.0%) | -$106.48 M(-4.7%) |
| Mar 2024 | - | -$32.08 M(+29.8%) | -$111.71 M(+1.0%) |
| Dec 2023 | -$110.58 M(+27.5%) | -$24.71 M(-6.0%) | -$110.58 M(+1.3%) |
| Sep 2023 | - | -$26.27 M(-8.3%) | -$109.19 M(+4.7%) |
| Jun 2023 | - | -$28.65 M(-7.4%) | -$104.27 M(+9.9%) |
| Mar 2023 | - | -$30.94 M(+32.7%) | -$94.84 M(+9.3%) |
| Dec 2022 | -$86.75 M | -$23.32 M(+9.2%) | -$86.75 M(-3.0%) |
| Sep 2022 | - | -$21.36 M(+11.1%) | -$89.43 M(-1.2%) |
| Jun 2022 | - | -$19.23 M(-15.8%) | -$90.50 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$22.85 M(-12.1%) | -$91.57 M(+6.7%) |
| Dec 2021 | -$85.85 M(+83.5%) | -$26.00 M(+15.9%) | -$85.85 M(+14.4%) |
| Sep 2021 | - | -$22.43 M(+10.5%) | -$75.03 M(+14.9%) |
| Jun 2021 | - | -$20.29 M(+18.5%) | -$65.28 M(+21.0%) |
| Mar 2021 | - | -$17.13 M(+12.9%) | -$53.93 M(+15.2%) |
| Dec 2020 | -$46.80 M(+77.0%) | -$15.18 M(+19.7%) | -$46.80 M(+48.0%) |
| Sep 2020 | - | -$12.68 M(+41.7%) | -$31.62 M(+66.9%) |
| Jun 2020 | - | -$8.94 M(-10.6%) | -$18.95 M(+89.4%) |
| Mar 2020 | - | -$10.00 M | -$10.00 M |
| Dec 2019 | -$26.45 M(+96.1%) | - | - |
| Dec 2018 | -$13.48 M | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual free cash flow?
- What is the all time high annual FCF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual FCF year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly FCF year-on-year change?
- What is Prelude Therapeutics Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM FCF year-on-year change?
What is Prelude Therapeutics Incorporated annual free cash flow?
The current annual FCF of PRLD is -$110.58 M
What is the all time high annual FCF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual free cash flow is -$13.48 M
What is Prelude Therapeutics Incorporated annual FCF year-on-year change?
Over the past year, PRLD annual free cash flow has changed by -$23.83 M (-27.47%)
What is Prelude Therapeutics Incorporated quarterly free cash flow?
The current quarterly FCF of PRLD is -$27.36 M
What is the all time high quarterly FCF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly free cash flow is -$8.94 M
What is Prelude Therapeutics Incorporated quarterly FCF year-on-year change?
Over the past year, PRLD quarterly free cash flow has changed by +$4.72 M (+14.72%)
What is Prelude Therapeutics Incorporated TTM free cash flow?
The current TTM FCF of PRLD is -$107.56 M
What is the all time high TTM FCF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM free cash flow is -$10.00 M
What is Prelude Therapeutics Incorporated TTM FCF year-on-year change?
Over the past year, PRLD TTM free cash flow has changed by +$4.15 M (+3.71%)